Connolly Sarah T. Amgen Inc Transaction History

Connolly Sarah T.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$218.65 - $271.46 $16,398 - $20,359	-75 Reduced 6.12%	1,150 $309,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $14,676 - $17,888	-65 Reduced 5.04%	1,225 $296,000
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $18,322 - $23,280	-80 Reduced 5.84%	1,290 $338,000
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $8,978 - $10,126	-40 Reduced 2.84%	1,370 $309,000
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $16,149 - $17,971	-70 Reduced 4.73%	1,410 $343,000
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $994 - $1,138	5 Added 0.34%	1,480 $333,000
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $319,160 - $380,063	1,475 New	1,475 $339,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Connolly Sarah T., based on Form 13F filings with the SEC.

Stay updated on Connolly Sarah T. with notifications on news.